Eli Lilly neutralizing antibody gets USFDA emergency use authorization for Covid treatment Ruchika Sharma11 Nov 2020 6:47 PM ISTIndianapolis: The U.S. Food and Drug Administration (USFDA) recently granted Emergency Use Authorization (EUA) for Eli Lilly and Company's...
Eli Lilly to acquire Disarm Therapeutics for USD 135 million Ruchika Sharma18 Oct 2020 9:45 AM ISTIndianapolis and Cambridge Drug major, Eli Lilly and Company, has recently announced a definitive agreement to acquire Disarm...
Setback: Eli Lilly halts Covid vaccine trial over safety concerns Ruchika Sharma14 Oct 2020 3:15 PM IST"Eli Lilly is supportive of the decision by the independent (Data Safety Monitoring Board) to cautiously ensure the safety of patients participating...
AstraZeneca, US strike deal for Covid-19 antibody treatment touted by Trump Ruchika Sharma11 Oct 2020 10:30 AM ISTAstraZeneca said it was planning to supply up to 1,00,000 doses starting toward the end of 2020 and that the U.S. government could acquire up to an...
Antibody therapy may lower COVID hospitalizations: Eli Lilly Ruchika Sharma18 Sept 2020 12:32 PM ISTIndianapolis: Eli Lilly and Co on Wednesday said a single infusion of its experimental antibody treatment reduced the need for hospitalization and...
Eli Lilly diabetes drug Trulicity gets USFDA nod Ruchika Sharma6 Sept 2020 10:15 AM ISTThe additional doses of Trulicity will be available in US pharmacies in late September.
Pharma firms test antibody drugs to treat, prevent Covid-19 Ruchika Sharma15 Aug 2020 9:00 AM ISTNew Delhi: With a coronavirus vaccine still months off, companies are rushing to test what may be the next best thing: drugs that deliver antibodies...
Indoco Remedies gets USFDA nod to Olanzapine Tablets to treat schizophrenia, bipolar disorder Ruchika Sharma9 Aug 2020 9:30 AM ISTMumbai: Indoco Remedies has recently announced receipt of approval for its ANDA for Olanzapine Tablets USP 2.5mg, 5mg, 7.5 mg, 10mg, 15mg and 20...
Eli Lilly starts phase 3 trial for COVID-19 antibody treatment Ruchika Sharma5 Aug 2020 11:15 AM ISTUS: American pharmaceutical firm Eli Lilly and Company has announced the start of its phase 3 trial to study whether one of its experimental...
Eli Lilly COVID-19 drug could be authorized for use in September: Report Ruchika Sharma13 Jun 2020 9:30 AM ISTA monoclonal antibody drug developed against COVID-19 is likely to be more effective than repurposed medicines currently being tested against the...
FIRST: Eli Lilly begins human trial of potential antibody treatment for COVID-19 Ruchika Sharma4 Jun 2020 9:30 AM ISTThis investigational medicine, referred to as LY-CoV555, is the first to emerge from the collaboration between Eli Lilly and AbCellera to create...
Reyvow available for acute treatment of migraine, announces Eli Lilly Medha Baranwal5 Feb 2020 9:30 AM ISTDelhi: New migraine treatment Reyvow (lasmiditan) has been launched by the pharmaceutical company Eli Lilly following its approval by USFDA in October...
